Scientists have discovered a possible mechanism for triggering lung fibrosis
With pulmonary fibrosis, healthy tissue is gradually replaced by scar tissue, which makes it more difficult for the organ to perform its function. For a long time, it remained unclear which cellular changes trigger this process. The researchers found that one of the early events may be a violation of lipid metabolism in the immune cells of the lungs. In experiments on mice, it led to the activation of cells forming scar tissue. The role this mechanism can play in the development of the disease is described in the Izvestia article.
Pulmonary fibrosis is a condition in which connective tissue accumulates in the lung tissue and scars form. Because of this, the lungs become less elastic, and oxygen supply to the blood becomes more difficult. The disease can progress and lead to respiratory failure.
How immune cells can trigger fibrosis
A study by scientists from the University of California at Los Angeles has been published in the American Journal of Respiratory Cell and Molecular Biology (AJRCMB). The authors studied alveolar macrophages, immune cells that are located in the air spaces of the lungs. Normally, they help protect tissues from damage, maintain their condition, and participate in recovery from injury.
The focus was on the protein ABCG1, which regulates cholesterol transport inside macrophages. Scientists studied mice with a deficiency of this protein and found that lipids, including cholesterol, rapidly accumulated in their alveolar macrophages. Moreover, the changes occurred even before the noticeable deposition of collagen and the formation of scar tissue.
Previously, lipid-saturated macrophages have already been detected in the lungs of patients with fibrosis. However, such cells were mainly considered as a consequence of the disease. The new work allowed us to test another hypothesis: whether a violation of lipid metabolism in immune cells can itself become one of the factors triggering pathological changes.
From lipid accumulation to scar formation
Further analysis showed that macrophages with impaired lipid metabolism are able to affect neighboring fibroblast cells. Normally, these cells are involved in tissue repair, but under certain conditions they become activated and begin to produce connective tissue components, including collagen. Its excessive accumulation leads to the formation of scars.
The researchers studied the lipid composition of macrophages and found in them an increased content of complex lipid molecules with polyunsaturated fatty acid chains. Similar changes were observed in cells isolated at the early stages of experimental fibrosis. In laboratory experiments, individual lipids directly activated fibroblasts and increased the expression of genes associated with the development of fibrotic changes.
Thus, scientists have traced a possible sequence of events: first, cholesterol processing is disrupted in alveolar macrophages and lipids accumulate, then they transmit signals to fibroblasts, and they begin to actively form connective tissue. This indicates the existence of a mechanism of interaction between immune cells and fibroblasts, which may be involved in triggering fibrosis.
Experiments have confirmed the role of macrophages
To test whether it is possible to influence the development of fibrosis through lipid metabolism, the researchers conducted additional experiments on rodents. In particular, they used bone marrow transplantation to restore the normal functioning of macrophages with the ABCG1 protein. After such an intervention, the mice were almost completely protected from the development of fibrosis.
In the reverse experiment, bone marrow transfer with ABCG1 deficiency to healthy animals proved to be sufficient to trigger fibrotic changes. These results support the assumption that a violation of lipid metabolism in macrophages may be not just a concomitant sign, but one of the factors initiating the disease.
The scientists also tested other methods of intervention. Restoration of cholesterol transport in macrophages and blocking of lipid uptake by fibroblasts prevented the development of fibrotic changes in animals. This indicates several potential points of influence on the discovered mechanism.
What discovery can change in the study of the disease
Today, existing approaches to the treatment of pulmonary fibrosis are mainly aimed at slowing the progression of an already formed disease. The new results suggest that in the future, attention may be given to earlier cellular changes, before a significant amount of scar tissue accumulates in the lungs.
One of the possible directions is the restoration of normal lipid metabolism in alveolar macrophages. Another is to prevent certain lipids from entering fibroblasts to prevent their activation. In addition, if such changes can be detected in humans at an early stage, they can potentially become additional risk markers.
However, the results cannot yet be directly transferred to patients: the study was conducted on mice, and the effectiveness and safety of such approaches for humans has yet to be tested. Scientists also need to find out how often the described mechanism is involved in the development of various forms of pulmonary fibrosis.
The work reveals one of the possible early mechanisms of the disease and shows that the interaction of immune cells with fibroblasts may be important even before the formation of pronounced scars. In the future, this will help to find ways to interfere with the development of fibrosis at an earlier stage, but additional research is needed before new diagnostic and treatment methods become available.
Переведено сервисом «Яндекс Переводчик»